Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

Weifei Zhu1, Jill C Gregory1, Elin Org2

  • 1Department of Cellular & Molecular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.

Cell
|March 15, 2016
PubMed

Insights

Gut microbes generate trimethylamine N-oxide (TMAO), a compound that directly increases platelet hyperreactivity and thrombosis risk. Higher TMAO plasma levels predict future heart attack and stroke events.

Area of Science:

  • Cardiovascular Biology
  • Microbiome Research
  • Hematology

Background:

  • Normal platelet function is essential for hemostasis.
  • Increased platelet reactivity is linked to cardiometabolic diseases and thrombosis.
  • The gut microbiome's role in platelet function is not fully understood.

Purpose of the Study:

  • To investigate the direct contribution of gut microbes and trimethylamine N-oxide (TMAO) to platelet hyperreactivity and thrombosis.
  • To establish a mechanistic link between diet, gut microbiota, TMAO, and thrombosis risk.

Main Methods:

  • Analysis of plasma TMAO levels in over 4,000 subjects for prediction of incident thrombosis.
  • In vitro studies exposing platelets to TMAO to assess activation.
  • Animal model studies using dietary interventions, germ-free mice, and microbial transplantation.

Main Results:

  • Elevated plasma TMAO levels independently predicted 3-year risk of thrombosis (heart attack, stroke).
  • TMAO exposure enhanced platelet activation via augmented intracellular calcium release.
  • Gut microbiota and TMAO were confirmed to modulate platelet hyperresponsiveness and thrombosis potential in vivo.

Conclusions:

  • Gut microbes, via TMAO production, directly promote platelet hyperreactivity and increase thrombosis risk.
  • A novel mechanistic pathway links dietary nutrients, gut microbiota, TMAO, platelet function, and thrombosis.
  • Specific microbial taxa associated with TMAO production and thrombosis potential were identified.